These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 8042820)

  • 1. The metyrapone and dexamethasone suppression tests for the differential diagnosis of the adrenocorticotropin-dependent Cushing syndrome: a comparison.
    Avgerinos PC; Yanovski JA; Oldfield EH; Nieman LK; Cutler GB
    Ann Intern Med; 1994 Sep; 121(5):318-27. PubMed ID: 8042820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine free cortisol in the high-dose dexamethasone suppression test for the differential diagnosis of the Cushing syndrome.
    Flack MR; Oldfield EH; Cutler GB; Zweig MH; Malley JD; Chrousos GP; Loriaux DL; Nieman LK
    Ann Intern Med; 1992 Feb; 116(3):211-7. PubMed ID: 1728204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the overnight and the standard metyrapone test for the differential diagnosis of adrenocorticotrophin-dependent Cushing's syndrome.
    Avgerinos PC; Nieman LK; Oldfield EH; Cutler GB
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):483-91. PubMed ID: 8959090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the distinction of ectopic and pituitary ACTH dependent Cushing's syndrome by clinical features, biochemical tests and radiological findings.
    Blunt SB; Sandler LM; Burrin JM; Joplin GF
    Q J Med; 1990 Nov; 77(283):1113-33. PubMed ID: 2177207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Aron DC; Raff H; Findling JW
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
    J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
    JAMA; 1993 May; 269(17):2232-8. PubMed ID: 8386285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative metyrapone test in the early assessment of outcome of pituitary surgery for Cushing's disease.
    van Aken MO; de Herder WW; van der Lely AJ; de Jong FH; Lamberts SW
    Clin Endocrinol (Oxf); 1997 Aug; 47(2):145-9. PubMed ID: 9302385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of efficacy between the serum cortisol and 24 hour urine free cortisol in combined dexamethasone suppression test in the diagnosis of Cushing syndrome].
    Lu L; Chen JH; Zhu HJ; Song AL; Li M; Chen S; Pan H; Gong FY; Wang RZ; Xing B; Yao Y; Feng M; Lu ZL
    Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(27):2150-4. PubMed ID: 27464539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
    Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of the 4-mg intravenous dexamethasone suppression test in differentiating Cushing disease from pseudo-Cushing syndrome.
    Nouvel M; Rabilloud M; Raverot V; Subtil F; Vouillarmet J; Thivolet C; Jouanneau E; Borson-Chazot F; Pugeat M; Raverot G
    Ann Endocrinol (Paris); 2016 Feb; 77(1):30-6. PubMed ID: 26656734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic tests for children who are referred for the investigation of Cushing syndrome.
    Batista DL; Riar J; Keil M; Stratakis CA
    Pediatrics; 2007 Sep; 120(3):e575-86. PubMed ID: 17698579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The superiority of the metyrapone test versus the high-dose dexamethasone test in the differential diagnosis of Cushing's syndrome.
    Sindler BH; Griffing GT; Melby JC
    Am J Med; 1983 Apr; 74(4):657-62. PubMed ID: 6837591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cushing's syndrome: diagnostic exploration].
    Tabarin A; Roger P
    Presse Med; 1994 Jan 8-15; 23(1):43-8. PubMed ID: 8127815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The low dose ACTH stimulation test is less sensitive than the overnight metyrapone test for the diagnosis of secondary hypoadrenalism.
    Soule S; Van Zyl Smit C; Parolis G; Attenborough S; Peter D; Kinvig S; Kinvig T; Coetzer E
    Clin Endocrinol (Oxf); 2000 Aug; 53(2):221-7. PubMed ID: 10931104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined stimulation of adrenocorticotropin and compound-S by single dose metyrapone test as an outpatient procedure to assess hypothalamic-pituitary-adrenal function.
    Berneis K; Staub JJ; Gessler A; Meier C; Girard J; Müller B
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5470-5. PubMed ID: 12466339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nocturnal high-dose dexamethasone suppression test in the aetiological diagnosis of Cushing's syndrome.
    Bruno OD; Rossi MA; Contreras LN; Gómez RM; Galparsoro G; Cazado E; Kral M; Leber B; Arias D
    Acta Endocrinol (Copenh); 1985 Jun; 109(2):158-62. PubMed ID: 2990131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cushing's syndrome: a diagnostic strategy].
    Bouallouche A; Vermeulen C; Brerault JL; Fiet J; Julien R; Guillevin L
    Sem Hop; 1984 Apr; 60(15):1083-8. PubMed ID: 6326300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous dexamethasone infusion for seven hours in patients with the Cushing syndrome. A superior differential diagnostic test.
    Biemond P; de Jong FH; Lamberts SW
    Ann Intern Med; 1990 May; 112(10):738-42. PubMed ID: 2158760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic value of hypothalamic-pituitary-adrenocortical function tests in patients with Cushing's syndrome.
    Hashimoto K
    Acta Med Okayama; 1975 Apr; 29(2):111-26. PubMed ID: 169671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.